Le Gall-Ianotto, C.
Verdet, R.
Nowak, E.
Le Roux, L.
Gasse, A.
Fiedler, A.
Carlhant-Kowalski, D.
Marcorelles, P.
Misery, L.
Ianotto, J. C.
Funding for this research was provided by:
phrci grand ouest
Article History
Received: 30 June 2021
Accepted: 23 November 2021
First Online: 19 December 2021
Declarations
:
: This study protocol as well as information and informed consent form has been approved by the ethical committee of Ile-De-France 8 in July 2018. ANSM has also approved the study. Signed and written informed consent will be obtained for all patients included in this study. Participants have the right to withdraw from the study at any time and for any reason.
: There is no need to obtain consent for publication since no identifying images or personal details of patients are presented.
: LM declares having interest with Novartis and UCB. JCI declares having interests with Novartis. The authors declare that they have no competing interests.